INDUCTION OF DONOR-SPECIFIC TOLERANCE IN PATIENTS WITH LIVER TRANSPLANTATION WITH RECIPIENT PRE-TREATMENT WITH THYMOGLOBULINE AND MINIMAL POST-TRANSPLANT IMMUNOSUPPRESSION. - ND

• Conditions: Adult recipients of first liver transplantation; MedDRA version: 9.1Level: LLTClassification code 10024715Term: Liver transplant rejection

• Registration Number: EUCTR2009-010640-34-IT
• Lead Sponsor: AZIENDA OSPEDALIERA POLICLINICO DI MODENA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-05-13
• Last Update Posted: 26 June 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients with first liver transplant procedure, even split or living-related, of age > 18 years, giving informed consent to inclusion in the study protocol
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1)Re-transplantation with any indication 2)HIV+ patients, or with tumours different from HCC 3)Recipients of multiorgan procedures 4)Patients with severe lymphopenia (< 1000 WBC/ul) or thrombocitopenia (< 50000 PLT/ul) pre-transplantation 5)Female patients in fertile age during pregnancy or breast-feeding

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified